Matthew Gerard Vicinanzo, M.D.
Ophthalmic Plastic and Reconstructive Surgery Physician · Birmingham, AL
Matthew Gerard Vicinanzo, M.D. is an ophthalmic plastic and reconstructive surgery physician with a practice address in Birmingham, Alabama, and NPI 1740283266, issued on May 30, 2005. Check the license (Alabama 25771, as entered in NPPES) on the Alabama Board of Medical Examiners; the Medicare figures below come from public CMS files.
- Name
- Matthew Gerard Vicinanzo
- Credential
- M.D.
- Primary taxonomy
- Ophthalmic Plastic and Reconstructive Surgery Physician 207WX0200X
- License number
- 25771 AL
Self-reported in NPPES; status is on the state search - Practice location
- 1000 19TH St S, Birmingham, AL 35205
- Phone
- (205) 930-0700
- Enumerated
- May 30, 2005
- Record last updated
- Apr 4, 2016 (not updated in 10 years: call before relying on the address or phone)
- Fax
- (205) 930-9127
- Medicaid ID
- 051520716 AL
- Medicare enrollment
- Enrolled (PECOS I20040603001080); accepts Medicare assignment
- Medical or professional school
- State University Of Ny Upstate Medical University, 2000
- Entity
- Type 1 · individual
Also registered at 1000 19TH St S
A shared address usually means a shared clinic or building; it does not show who employs whom.
- Kristin Bains, M.D.Ophthalmology Physician1386847374
- Jennifer Davidson, M.D.Pediatric Ophthalmology and Strabismus Specialist Physician1528379716
- Adam De La Garza, MDOphthalmology Physician1609805522
- Frederick Elsas, M.D.Ophthalmology Physician1225031743
- Roger Henry, MDOphthalmology Physician1801532536
- Colette Jackson, MDPediatric Ophthalmology and Strabismus Specialist Physician1174943138
Verify Matthew Gerard Vicinanzo in five checks
- 1IdentityNPI record in CMS NPPESNPI lookupConfirmed in NPPES
- 2LicenseActive license and public ordersAlabama Board of Medical Examiners
Search for license 25771Check the board - 3Other statesLicenses and actions elsewhereDocInfo (FSMB)Not checked
- 4ExclusionsMedicare and Medicaid bansHHS-OIG exclusion listNot checked
- 5CertificationBoard certificationABMS AOA NCCPA AANPNot checked
58% more Medicare Part D claims than the average ophthalmic plastic and reconstructive surgery physician in 2024
861 Medicare Part D claims for 386 beneficiaries, against an average of 544 among the 409 providers of this specialty who prescribed in Part D. Brand-name drugs were 7% of claims. 248 claims were for opioids.
Most prescribed
- Tramadol Hcl240 claims
- Erythromycin218 claims
- Neomycin-Polymyxin-Dexameth134 claims
- Cefadroxil71 claims
- Methylprednisolone34 claims
- Polymyxin B Sul-Trimethoprim19 claims
Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.
No measured MIPS final score for 2023
CMS assigned the neutral MIPS final score of 75 without scoring Quality, Cost, Promoting Interoperability or Improvement Activities. It is an administrative threshold, so PlainDoctor does not compare it with measured clinicians.
Source: CMS Quality Payment Program, MIPS performance year 2023, group reporting; category weights for 2023 (qpp.cms.gov).
Industry payments in 2024: $292.17
21 payments; by number, the most common kind was food and beverage; the largest payer was Amgen Inc. The 332 providers of this specialty with any payment received $6,302.89 on average. Payments are reported by manufacturers, not by the provider, and are not a sign of wrongdoing.
Source: CMS Open Payments, program year 2024 (openpaymentsdata.cms.gov); average among providers of this specialty with at least one payment.
Bills Medicare through one group practice
- Alabama Ophthalmology Associates, P.C.Birmingham, AL
Source: CMS Doctors and Clinicians National Downloadable File (the group practices a clinician bills Medicare through) (data.cms.gov).
Ophthalmic Plastic and Reconstructive Surgery Physician providers in Alabama
There are 4 ophthalmic plastic and reconstructive surgery physician records in Alabama.
Other ophthalmic plastic and reconstructive surgery physician records in Alabama
- Mark Brown, MDMobile, AL1114999729
- John Long, M.D.Birmingham, AL1861495384
- Carrie Morris, MDGulf Shores, AL1437294063
Common questions
What is Matthew Gerard Vicinanzo, M.D.'s NPI number?
Matthew Gerard Vicinanzo, M.D.'s National Provider Identifier (NPI) is 1740283266, issued on May 30, 2005. An NPI identifies a provider in billing; it is not a license.
Where is Matthew Gerard Vicinanzo, M.D. located?
The NPPES record lists a practice address at 1000 19TH St S, Birmingham, AL, 35205. Phone: (205) 930-0700. Providers update this record themselves, so call before visiting.
How can I verify Matthew Gerard Vicinanzo, M.D.'s license?
NPPES lists Alabama license number 25771, as entered by the provider. Search the Alabama Board of Medical Examiners at https://www.albme.gov/. The NPPES record confirms identity only; the state search shows license status, expiration and public orders.
How much does Matthew Gerard Vicinanzo, M.D. prescribe under Medicare Part D?
In 2024, Matthew Gerard Vicinanzo, M.D. had 861 Medicare Part D claims for 386 beneficiaries; the average among ophthalmic plastic and reconstructive surgery physician prescribers was 544. Part D covers Medicare prescriptions only.
What is Matthew Gerard Vicinanzo, M.D.'s MIPS final score?
CMS assigned the neutral MIPS final score of 75 for 2023 without scoring any category, so it is not a measured result.
Source: CMS National Plan and Provider Enumeration System (NPPES), file of Aug 9, 2026 (NPPES files on CMS.gov); NUCC Health Care Provider Taxonomy. Medicare files from data.cms.gov. An NPI identifies who bills; it is not a license.
Figures on PlainDoctor are read from the federal files each page names (CMS NPPES, Medicare Part D, MIPS, Open Payments; the HHS-OIG exclusion list only as counts) and from Census population estimates, with the file date shown beside them. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of Aug 9, 2026.